Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens

Brain Research

Volumn 707, Issue 1, 1996, Pages 75-80

  Turgeon, Sarah M ^a   Pollack, Alexia E ^a   Schusheim, Leana ^a   Fink, J Stephen ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adenosine; Amphetamine; APEC; c Fos; CHA; Nucleus accumbens; Striatum

Indexed keywords

2 [(2 AMINOETHYLAMINO)CARBONYLETHYLPHENYLETHYLAMINO] 5 N ETHYLCARBOXAMIDOADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; AMPHETAMINE; CYCLOHEXYLADENOSINE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

ADENOSINE; AMPHETAMINE; ANIMALS; CELL COUNT; CORPUS STRIATUM; LOCOMOTION; MALE; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1;

EID: 0030029608     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01223-0     Document Type: Article

References (29)

1. Alexander, S.P. and Reddington, M., The cellular localization of adenosine receptors in rat neostriatum, Neuroscience, 28 (1989) 645-651.
2. 2 adenosine receptor labeled by [3H]NECA in rat striatal membranes, Mol. Pharmacol., 29 (1986) 331-346.
3. Creese, I. and Iverson, S.D., The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat, Psychopharmacologia (Berl.), 39 (1974) 345-357.
4. Di Chiara, G., Morelli, M. and Consolo, S., Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions, Trends Neurosci., 17 (1994) 228-233.
5. Drew, K.L. and Glick, S.D., Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response, Psychopharmacology, 101 (1990) 465-471.
6. 2-mediated behaviour in short-term reserpinized mice, Eur. J. Pharmacol., 192 (1991) 25-30.
7. Ferre, S., O'Conner, W.T., Fuxe, K. and Ungerstedt, U., The striatopallidal neuron: A main locus for adenosine-dopamine interactions in the brain, J. Neurosci., 13 (1993) 5402-5406.
8. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia, Neuroscience, 63 (1994) 765-773.
9. 1 receptors, Neuroreport, 6 (1994) 73-76.
10. 2 receptor induces catalepsy, Neurosci. Lett., 130 (1991) 162-164.
11. Ferre, S., von Euler, G., Johansson, B., Fredholm, B. and Fuxe, K., Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes, Proc. Natl. Acad. Sci. USA, 88 (1991) 7237-7241.
12. Fink, J.S. and Smith, G.P., Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine, Brain Res., 201 (1980) 107-127.
13. 2 dopamine receptors in rat striatum, Mol. Brain Res., 14 (1992) 186-195.
14. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
15. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
16. Heffner, T.G., Wiley, J.N., Williams, A.E., Bruns, R.F., Coughenour, L.L. and Downs, D.A., Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice, Psychopharmacol, 98 (1989) 31-37.
17. 2-selective agonist [3H]CGS 21680, Eur. J. Pharmacol., 168 (1989) 243-246.
18. Kawaguchi, Y., Wilson, C.J. and Emson, P.C., Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin, J. Neurosci., 10 (1990) 3421-3438.
19. 6-benzyladenosine-5′-uronamides enhances selectivity for A3 receptors, J. Med. Chem., 37 (1994) 3614-3621.
20. 2 receptors: selective localization in the human basal ganglia and alterations with disease, Neuroscience, 42 (1991) 697-706.
21. 2 receptors in unilaterally 6-hydroxydopamine lesioned rats, Eur. J. Pharmacol., 251 (1994) 21-25.
22. Nguyen, T.V., Kosofsky, B.E., Birnbaum, R., Cohen, B.M. and Hyman, S.E., Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine, Proc. Natl. Acad. Sci. USA, 89 (1992) 4270-4274.
23. 2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand, Naunyn Schmiedeberg's Arch. Pharmacol., 342 (1990) 85-89.
24. Parsons, B., Tagazaki, D., Kassir, S. and Przedborski, S., Effects of chronic blockade of dopamine-2 or adenosine-2 receptors in rat striatum, Movement Disorders, (1994) 490-491.
25. 2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons, Brain Res., 361(1993) 161-166.
26. 2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats, Eur. J. Pharmacol., 257 (1994) 21-25.
27. 1-adenosine receptor that is widely expressed in brain and spinal cord, Mol. Endocrinol., 5 (1991) 1037-1048.
28. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemical study, J. Neurochem., 57 (1991) 1062-1067.
29. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons, J. Neurosci., 13 (1993) 1080-1087.